GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (B5RCZ4)

Analyse AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B5RCZ4
Type
protein
Length
388 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x024E776336F8eD4B2eC1b7523E5a42EABB50f840
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
B5RCZ4
Pockets
6 · best druggability 0.83

Structure

1 distinct chain · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein38838% helix, 18% strandB5RCZ4

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11930.830.9730empty
24000.670.8038empty
32660.520.7537empty
4500.450.8517empty
5940.390.7717empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.